$215.66
-3.60 (-1.64%)
OSIS News30 articles
Plug Power's Cash Position and Project Progress Under Scrutiny
Plug Power shares closed at $2.85, up 7.55% on Thursday, but the market's focus remains on liquidity challenges and the company's ability to monetize projects.
Pelosi Family Maintains Large AI and Tech Holdings Despite Recent Sales
House filings show Pelosi family retains major positions in top tech stocks despite recent large sales, as semiconductor gains boost Nasdaq.
Moderna Shares Surge on Positive FDA Staff Review for mRNA Flu Vaccine
Moderna shares surged nearly 10% to $57.19 after FDA staff said data on its mRNA flu shot may support effectiveness in adults 65+, lowering regulatory risk ahead of a key advisory panel vote.
Keel Infrastructure Rallies on Closing $458M AI Data Center Financing
Keel Infrastructure Corp. shares surged 5.14% after closing $458 million in convertible notes to accelerate AI and high-performance computing data center projects.
Ether ETF Inflow Breaks 17-Day Losing Streak, Yet Price Continues Decline
U.S. spot ether ETFs ended a 17-day outflow streak with a $19 million inflow on June 4, but ether's price fell 6% to $1,662, as bearish sentiment persists.
Abivax Stock Tumbles 44% Despite Positive Ulcerative Colitis Trial Results
Abivax shares fell 44% as strong Phase 3 results for obefazimod in ulcerative colitis were overshadowed by malignancy cases, fueling investor worries about regulatory approval.
Abivax shares drop despite positive Phase 3 results for ulcerative colitis drug
Abivax shares plunged 33.7% after hours despite obefazimod achieving clinical remission in over 50% of patients in a Phase 3 trial. The company plans to submit an FDA application in late Q4 2026.
Blue Origin Explosion Casts Shadow on AST SpaceMobile's 2026 Satellite Plans
AST SpaceMobile stock plunged 14.79% Friday after a Blue Origin New Glenn rocket explosion raised doubts about its 2026 satellite rollout. Deutsche Bank cut its rating to Hold, slashing the price target to $106.
Intuitive Machines Slips After Losing Out on Key NASA Lunar Rover Contract
Intuitive Machines shares dropped 8.1% after NASA awarded key lunar rover contracts to competitors. The company remains engaged in other NASA lunar projects.
AbbVie Stock Gains on Positive Pipeline Updates Ahead of Holiday
AbbVie closed Friday at $215.70, up 0.56%, after receiving a positive EU panel recommendation for MAVIRET in acute hepatitis C and releasing new oncology data ahead of ASCO.
IREN Retreats After Nvidia-Led Rally, Week Still Positive
IREN shares dropped 2.1% to $56.83 Friday, ending a two-day rally, but still closed the week up 7.4% on Nvidia AI cloud deals and a $3B convertible note.
POET Technologies Surges 11% After Closing $400M Offering; Revenue Concerns Persist
POET Technologies shares climbed 11% to $14.55 after closing a $400 million direct offering, bouncing back from an 8% drop on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million.
SAP Shares Surge on AI Optimism and Positive Analyst Ratings
SAP SE shares jumped 5.8% on Tuesday, buoyed by AI-related announcements and favorable analyst coverage, though the stock remains down 25% for the year.
IREN Stock Tumbles 9% After Closing $3B Convertible Note Deal for Nvidia AI Push
IREN shares dropped 9.35% to $52.94 Friday after closing a $3.0 billion convertible-note sale for its Nvidia AI infrastructure expansion, ending the week down 13.5%.
USBC Soars on Tight Float and Tokenized Deposit Buzz
USBC shares surged 59% on heavy volume, fueled by tokenized deposit plans and Bitcoin treasury strategy, despite no new corporate announcements.
GSI Technology Surges 39% on Strong Revenue, Cash Position, and Edge AI Focus
GSI Technology shares surged 39% on Monday following a 22% revenue increase and a strong cash position, highlighting its edge AI push.
Amkor Technology Gains 6% After Closing $1.15B Convertible Note Deal
Amkor Technology shares rose 6% to $76.61 after the company completed a $1.15 billion convertible note offering to expand its advanced packaging capacity.
Avalo Therapeutics Soars 34% on $375M Offering Following Positive Phase 2 HS Data
Avalo Therapeutics shares surged 34% after pricing a $375M public offering, following positive Phase 2 results for abdakibart in hidradenitis suppurativa. The company aims to fund Phase 3 development.
Cellectar Biosciences Secures $140M, Pushes Iopofosine Toward FDA Filing
Cellectar Biosciences secured up to $140 million in new funding and reported strong Phase 2b results for iopofosine, fueling plans for a confirmatory trial and FDA filing in Waldenström macroglobulinemia.
Ballard Power Shares Surge 24% on Narrowed Q1 Loss, Positive Gross Margin
Ballard Power Systems (BLDP) shares surged about 24% after Q1 revenue climbed 26% to $19.4M and net loss narrowed to $0.04 per share, helped by cost reductions and a positive gross margin of 14%.
ASX 200 Extends Losing Streak as Inflation and Oil Shock Weigh on Sentiment
Australian shares slipped for an eighth consecutive day, with the ASX 200 closing 0.24% lower, as inflation data and a profit warning from Woolworths dragged on the market.
KPMG Exits Federal Audit After Losing Pentagon Contract
KPMG will wind down its US federal audit unit after losing a $60 million Pentagon contract, reassigning over 450 employees. The Pentagon is consolidating audits to achieve a clean opinion by 2028.
ASX 200 Extends Losing Streak as Inflation Surprises
The ASX 200 fell 0.27% to 8,687, its seventh consecutive decline, after inflation accelerated to 4.6% in March, raising the odds of an RBA rate hike.
ASX 200 Stretches Losing Streak to Five Sessions as Energy and Bank Stocks Weigh
The S&P/ASX 200 declined for a fifth consecutive session, losing 20.1 points to 8,766.40, as energy, utility, and bank stocks dragged. Origin Energy plunged 5.25%, while Atlas Arteria jumped on a takeover offer.
ASX 200 Extends Losing Streak as Oil Tensions Divide Market Ahead of RBA Decision
Australian shares fell for a fourth straight session, with the ASX 200 down 0.1% to 8,786.5 as oil above $105 a barrel fueled a rotation into energy and utilities. Suncorp gained 4.9% on a new reinsurance deal, while IGO slumped 17.3% on lower production guidance.
Institutional Investors Adjust Alphabet Positions Ahead of Q1 Earnings
Recent 13F filings show mixed institutional moves in Alphabet shares as the market awaits first-quarter results on April 29. Zevenbergen boosted its Class A position while two other firms reduced Class C holdings.
Shanghai Composite Tumbles 0.8%, Posts Steepest Monthly Drop Since Early 2022
The Shanghai Composite Index declined 0.8% to 3,891.86, marking its worst monthly performance since January 2022. Losses came despite an official manufacturing PMI reading that beat forecasts.
Shenzhen Market Plunges as Growth Stocks Retreat Despite Positive Factory Data
Shenzhen stocks declined sharply on Tuesday, with the ChiNext board dropping 2.7%, as investor concerns over energy prices and supply chain risks overshadowed positive manufacturing data.
Vanguard Exits Major SoundHound AI Position Amid Strategic Shift
Vanguard has dropped below the 5% ownership threshold in SoundHound AI following an internal restructuring. The conversational AI firm reported 2025 revenue of $168.9 million, nearly double the prior year, and projects 2026 revenue between $225 million and $260 million.
Eli Lilly Inks $2.75B AI Drug Deal, Posts Positive Trial Data
Eli Lilly has entered a licensing deal with Insilico Medicine potentially worth $2.75 billion and reported strong late-stage clinical results for its immunology and obesity drugs.